WCK 6777 is the only once-a-day drug in global antibiotic pipeline designed for outpatient parenteral antimicrobial therapy
MNI is dedicated to developing and offering phytochemical (plant-based) products and healthcare solutions, aimed at treating metabolic syndrome
Poor oral health (periodontal disease) impacts nearly 51% of Indians
MoU signed to drive digital transformation through strategic projects across all three business sectors of Merck
Secretary Vaidya Rajesh Kotecha has urged senior officials to strive for the successful attainment of targets during the campaign
The Academy, led by Professor Ravi P Mahajan CBE, is set to harmonize the efforts of various Apollo entities
Effective, holistic, science-backed targeted solutions for symptomatic treatment
The company is making its mark through strategic initiatives, promising to become a significant presence in the evolving pharmaceutical sector
The grant is designated for the research and development of Pyronaridine
Subscribe To Our Newsletter & Stay Updated
